title: Phase I Trial: SABR and Ipilimumab-Letter.
authors.affiliation: Department of Radiation Oncology, Stanford University Medical Center and Cancer Institute, Stanford, California. shiniker@stanford.edu.
authors.forename: Susan M
authors.initials: SM
authors.lastname: Hiniker
authors.affiliation: Department of Medicine, Division of Oncology, Stanford University Medical Center and Cancer Institute, Stanford, California.
authors.forename: Sunil A
authors.initials: SA
authors.lastname: Reddy
authors.affiliation: Department of Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Stanford, California.|Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
authors.forename: Susan M
authors.initials: SM
authors.lastname: Swetter
authors.affiliation: Department of Radiation Oncology, Stanford University Medical Center and Cancer Institute, Stanford, California.
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Knox
mesh_terms: D006801:Humans; D000074324:Ipilimumab; D008175:Lung Neoplasms / Q000601:surgery; D016634:Radiosurgery; D013601:T-Lymphocytes
chemical_list: D000074324:Ipilimumab